Director, International Policy Analytics
Bristol Myers Squibb
5 hours ago
Remote friendly (Princeton, NJ)
United States
Market Access
Position Summary
The Director, International Policy Analytics will lead analytical assessments of ex U.S. pharmaceutical policy and pricing reforms, translating complex international policy developments into decision-ready insights that inform enterprise strategy, policy research evidence generation, and external policy engagement. Focus includes impact of policies related to government pricing, reimbursement, and trade policies across priority international markets (including Europe, Asia-Pacific, and other key geographies).
Key Responsibilities
- Lead analytical assessments of international pharmaceutical policy reforms across priority ex U.S. markets (pricing, reimbursement, access, HTA, and trade-related policies).
- Develop, maintain, and apply analytical frameworks and models to assess portfolio and enterprise impact of international government pricing and reimbursement policies.
- Monitor and interpret international statutes, regulations, policy guidance, and HTA processes; translate market-specific developments into actionable insights.
- Produce robust analyses to support policy research evidence generation (international policy positions, evidence packages, advocacy narratives).
- Provide analytics supporting external policy engagement with governments, regulators, HTA bodies, and other stakeholders.
- Assess cross-market and spillover effects of international policy reforms (e.g., reference pricing, trade dynamics, global affordability initiatives) on enterprise strategy.
- Prepare executive-ready presentations and written materials communicating findings, uncertainties, and strategic tradeoffs to senior leadership.
- Collaborate cross-functionally with Global Health Systems Analytics, Global Pricing, Global Market Access (MAx), Regional Market Access, Legal, HEOR, Finance, and Business Insights & Technology (BIT).
- Track emerging international policy trends; identify risks and opportunities and escalate insights/recommendations.
- Leverage digital tools and AI-enabled analytics to improve rigor, efficiency, and scalability.
- Provide guidance, prioritization, and quality oversight for analytics deliverables.
- Mentor and develop team members; contribute to Global Policy Analytics capability-building.
Qualifications
- Advanced degree preferred (e.g., MPH, MPP, MBA, PhD, PharmD, or equivalent).
- 7-10+ years of experience in international health policy, pricing, reimbursement, HTA, or policy analytics.
- Strong understanding of international pharmaceutical policy frameworks (government pricing, reimbursement systems, HTA processes, access policies).
- Experience analyzing cross-market policy dynamics and their impact on global portfolio strategy.
- Ability to synthesize complex, heterogeneous policy environments into clear, actionable insights.
- Strong written and verbal communication skills; experience supporting executive-level discussions.
- Ability to operate effectively in ambiguous, fast-moving international policy environments.
- Experience in cross-functional, matrixed organizations.
- Interest in leadership and mentoring; potential growth into broader workstream or people leadership roles.
- Familiarity with and willingness to engage with digital or AI-enabled analytics tools.
Compensation/Benefits (as stated)
- Princeton, NJ: US $206,210–$249,878; Washington, DC: US $206,210–$249,878.
- Additional incentive cash and stock opportunities may be available (based on eligibility).
- Benefits include health coverage; wellbeing support programs; financial wellbeing/protection (401(k), disability, life insurance, etc.); paid time off (flexible time off/annual vacation details per employee category) and other time-off options based on eligibility.
Application Instructions
- Apply even if the role does not perfectly line up with your resume.
The Director, International Policy Analytics will lead analytical assessments of ex U.S. pharmaceutical policy and pricing reforms, translating complex international policy developments into decision-ready insights that inform enterprise strategy, policy research evidence generation, and external policy engagement. Focus includes impact of policies related to government pricing, reimbursement, and trade policies across priority international markets (including Europe, Asia-Pacific, and other key geographies).
Key Responsibilities
- Lead analytical assessments of international pharmaceutical policy reforms across priority ex U.S. markets (pricing, reimbursement, access, HTA, and trade-related policies).
- Develop, maintain, and apply analytical frameworks and models to assess portfolio and enterprise impact of international government pricing and reimbursement policies.
- Monitor and interpret international statutes, regulations, policy guidance, and HTA processes; translate market-specific developments into actionable insights.
- Produce robust analyses to support policy research evidence generation (international policy positions, evidence packages, advocacy narratives).
- Provide analytics supporting external policy engagement with governments, regulators, HTA bodies, and other stakeholders.
- Assess cross-market and spillover effects of international policy reforms (e.g., reference pricing, trade dynamics, global affordability initiatives) on enterprise strategy.
- Prepare executive-ready presentations and written materials communicating findings, uncertainties, and strategic tradeoffs to senior leadership.
- Collaborate cross-functionally with Global Health Systems Analytics, Global Pricing, Global Market Access (MAx), Regional Market Access, Legal, HEOR, Finance, and Business Insights & Technology (BIT).
- Track emerging international policy trends; identify risks and opportunities and escalate insights/recommendations.
- Leverage digital tools and AI-enabled analytics to improve rigor, efficiency, and scalability.
- Provide guidance, prioritization, and quality oversight for analytics deliverables.
- Mentor and develop team members; contribute to Global Policy Analytics capability-building.
Qualifications
- Advanced degree preferred (e.g., MPH, MPP, MBA, PhD, PharmD, or equivalent).
- 7-10+ years of experience in international health policy, pricing, reimbursement, HTA, or policy analytics.
- Strong understanding of international pharmaceutical policy frameworks (government pricing, reimbursement systems, HTA processes, access policies).
- Experience analyzing cross-market policy dynamics and their impact on global portfolio strategy.
- Ability to synthesize complex, heterogeneous policy environments into clear, actionable insights.
- Strong written and verbal communication skills; experience supporting executive-level discussions.
- Ability to operate effectively in ambiguous, fast-moving international policy environments.
- Experience in cross-functional, matrixed organizations.
- Interest in leadership and mentoring; potential growth into broader workstream or people leadership roles.
- Familiarity with and willingness to engage with digital or AI-enabled analytics tools.
Compensation/Benefits (as stated)
- Princeton, NJ: US $206,210–$249,878; Washington, DC: US $206,210–$249,878.
- Additional incentive cash and stock opportunities may be available (based on eligibility).
- Benefits include health coverage; wellbeing support programs; financial wellbeing/protection (401(k), disability, life insurance, etc.); paid time off (flexible time off/annual vacation details per employee category) and other time-off options based on eligibility.
Application Instructions
- Apply even if the role does not perfectly line up with your resume.